Sorafenib With Interferon Alfa-2b As First-Line Treatment of Advanced Renal Carcinoma: A Phase II Study of the Southwest Oncology Group

Christopher W. Ryan(Oregon Health & Science University), E. David Crawford(Oregon Health & Science University)
Journal of Clinical Oncology
July 30, 2007
Cited by 152


Related Papers

No related papers found

Powered by citation graph analysis